Susan Willavize

855 total citations
31 papers, 653 citations indexed

About

Susan Willavize is a scholar working on Pharmacology, Oncology and Molecular Medicine. According to data from OpenAlex, Susan Willavize has authored 31 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 7 papers in Oncology and 7 papers in Molecular Medicine. Recurrent topics in Susan Willavize's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Susan Willavize is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Pharmacogenetics and Drug Metabolism (5 papers). Susan Willavize collaborates with scholars based in United States, United Kingdom and Sweden. Susan Willavize's co-authors include H. Friedman, Rongyue Teng, John Vincent, John Vincent, George Foulds, Klaus Rave, Lutz Heinemann, Sue Sha, S. Bott and R. H. A. Becker and has published in prestigious journals such as Diabetes Care, Antimicrobial Agents and Chemotherapy and Pharmaceutical Research.

In The Last Decade

Susan Willavize

29 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Willavize United States 14 232 183 116 109 94 31 653
J.M. Brogard France 14 308 1.3× 119 0.7× 106 0.9× 119 1.1× 87 0.9× 63 672
Mark A. Gill United States 17 422 1.8× 199 1.1× 157 1.4× 105 1.0× 78 0.8× 60 987
Allan H. Price United Kingdom 7 360 1.6× 160 0.9× 175 1.5× 102 0.9× 69 0.7× 9 1.0k
Hidetoshi Furuie Japan 13 127 0.5× 120 0.7× 97 0.8× 69 0.6× 75 0.8× 32 635
Vanessa L. Herring United States 15 330 1.4× 134 0.7× 78 0.7× 71 0.7× 52 0.6× 20 916
A N Nafziger United States 9 291 1.3× 118 0.6× 71 0.6× 32 0.3× 129 1.4× 10 784
B J Crump United Kingdom 8 244 1.1× 159 0.9× 105 0.9× 41 0.4× 66 0.7× 9 816
Andrew D. Blair United States 16 270 1.2× 163 0.9× 55 0.5× 126 1.2× 156 1.7× 31 901
B. Lenfant France 15 230 1.0× 267 1.5× 111 1.0× 103 0.9× 30 0.3× 26 682
Donald S. North United States 12 229 1.0× 209 1.1× 101 0.9× 54 0.5× 36 0.4× 23 610

Countries citing papers authored by Susan Willavize

Since Specialization
Citations

This map shows the geographic impact of Susan Willavize's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Willavize with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Willavize more than expected).

Fields of papers citing papers by Susan Willavize

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Willavize. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Willavize. The network helps show where Susan Willavize may publish in the future.

Co-authorship network of co-authors of Susan Willavize

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Willavize. A scholar is included among the top collaborators of Susan Willavize based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Willavize. Susan Willavize is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Willavize, Susan, Miia Kivipelto, David L. Sparks, et al.. (2009). P1‐260: Disease progression of cognitive impairment in Alzheimer's disease: A model‐based approach. Alzheimer s & Dementia. 5(4S_Part_8). 1 indexed citations
2.
Burstein, Aaron H., et al.. (2008). Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers. European Journal of Clinical Pharmacology. 64(11). 1101–1109. 13 indexed citations
3.
Willavize, Susan & Elizabeth Morgenthien. (2007). Nonparametric confidence intervals for Tmax in sequence‐stratified crossover studies. Pharmaceutical Statistics. 7(1). 9–19. 3 indexed citations
4.
Burstein, Aaron H., David J. Clark, Melissa O’Gorman, et al.. (2007). Lack of Pharmacokinetic and Pharmacodynamic Interactions Between a Smoking Cessation Therapy, Varenicline, and Warfarin: An In Vivo and In Vitro Study1. The Journal of Clinical Pharmacology. 47(11). 1421–1429. 10 indexed citations
5.
Willavize, Susan & Elizabeth Morgenthien. (2006). Comparison of models for average bioequivalence in replicated crossover designs. Pharmaceutical Statistics. 5(3). 201–211. 7 indexed citations
6.
Henry, Robert R., Robert J. Fountaine, Susan Willavize, Jeannine M. Fisher, & David A. Fryburg. (2005). Abstract #884: Intrasubject Variability of Exubera Factors Comparable to Those for Subcutaneously Administered Regular Insulin in Patients with Type 2 Diabetes. Endocrine Practice. 11. 28–29. 5 indexed citations
7.
Vincent, John, et al.. (2000). Lack of effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of amlodipine. British Journal of Clinical Pharmacology. 50(5). 455–463. 45 indexed citations
8.
Ferguson, J., et al.. (2000). A comparison of the photosensitizing potential of trovafloxacin with that of other quinolones in healthy subjects. Journal of Antimicrobial Chemotherapy. 45(4). 503–509. 19 indexed citations
9.
Apseloff, Glen, et al.. (1998). Comparison of Azithromycin and Clarithromycin in Their Interactions with Rifabutin in Healthy Volunteers. The Journal of Clinical Pharmacology. 38(9). 830–835. 30 indexed citations
10.
Vincent, John, et al.. (1998). The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects. The American Journal of Surgery. 176(6). 23S–26S. 12 indexed citations
11.
Purkins, Lynn, S. Oliver, & Susan Willavize. (1998). An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin. European Journal of Clinical Microbiology & Infectious Diseases. 17(6). 431–433. 1 indexed citations
12.
Hoepelman, Andy I. M., et al.. (1998). A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers. The American Journal of Surgery. 176(6). 27S–31S. 12 indexed citations
13.
Vincent, John, et al.. (1998). The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects. The American Journal of Surgery. 176(6). 32S–38S. 14 indexed citations
14.
Vincent, John, et al.. (1998). Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans. European Journal of Clinical Microbiology & Infectious Diseases. 17(6). 427–430. 20 indexed citations
15.
Teng, Rongyue, et al.. (1997). Oral bioavailability of trovafloxacin with and without food in healthy volunteers. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 87–92. 43 indexed citations
16.
Vincent, John, et al.. (1997). Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 81–86. 31 indexed citations
17.
Vincent, John, Jürgen Venitz, Rongyue Teng, et al.. (1997). Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 75–80. 59 indexed citations
18.
Teng, Rongyue, et al.. (1997). Effect of Maalox and omeprazole on the bioavailability of trovafloxacin. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 93–97. 26 indexed citations
19.
Foulds, George, David R. Luke, Rongyue Teng, et al.. (1996). The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension. Journal of Antimicrobial Chemotherapy. 37(suppl C). 37–44. 43 indexed citations
20.
Willavize, Susan, et al.. (1996). The effects of orally administered theophylline on the pharmacokinetics and pharmacodynamics of dofetilide.. Clinical Pharmacology & Therapeutics. 59(2). 182–182. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.M. Brogard Breakdown of academic impact, for papers by Mark A. Gill Breakdown of academic impact, for papers by Allan H. Price Breakdown of academic impact, for papers by Hidetoshi Furuie Breakdown of academic impact, for papers by Vanessa L. Herring Breakdown of academic impact, for papers by A N Nafziger Breakdown of academic impact, for papers by B J Crump Breakdown of academic impact, for papers by Andrew D. Blair Breakdown of academic impact, for papers by B. Lenfant Breakdown of academic impact, for papers by Donald S. North
Rankless by CCL
2026